Product Name | MF | CAS | Details |
---|
Imazalil Sulfate | C14H14Cl2N2O.H2O4S | 58594-72-2 | Details |
Imazalil Base | C14H14Cl2N2O | 35554-44-0 | Details |
(+)-Nootkatone | C15H22O | 4674-50-4 | Details |
(-)-Ambroxide | C16H28O | 6790-58-5 | Details |
(S)-2-chloro-1-(3,4-difluorophenyl)ethanol | C8H7ClF2O | 1006376-60-8 | Details |
S-(+)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)-1-propylamide | C9H15NOS | 132335-44-5 | Details |
(S)-2-chloro-1-(2,4-dichlorophenyl)ethanol | C8H7Cl3O | 126534-31-4 | Details |
Squalene | C30H50 | 7683-64-9 | Details |
Ceramide 3B | C24H47NO3 | 100403-19-8 | Details |
Phytosphingosine | C18H39NO3 | 554-62-1 | Details |
Tetraacetylphytosphingosine | C26H47NO7 | 13018-48-9 | Details |
N-Acetylphytosphingosine (NAPS) | C20H41NO4 | 21830-28-4 | Details |
Salicyloyl phytosphingosine | C25H43NO5 | 212908-67-3 | Details |
(+)-Valencene | C15H24 | 4630-07-3 | Details |
N-nitroso Desmethyl rivastigmine | Details |
N-nitroso N-Desmethyl Trimebutine | Details |
N-nitroso Desmethyl Tamoxifen | Details |
N-nitroso N-Desmethyl Erythromycin EP impurity A | Details |
N-nitroso Niraparib | Details |
Methyl (1S,2S,3S,4R)-3-((S)-1-amino-2-ethylbutyl)-4-((tert-butoxycarbonyl)amino)-2-hydroxycyclopentane-1-carboxylate | C18H34N2O5 | 316173-29-2 | Details |
Baloxavir Intermediate | C17H17N3O4 | 1985607-70-2 | Details |
Baloxavir | C24H19F2N3O4S | 1985605-59-1 | Details |
(R)-3-(4-Bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanamide | C11H16BrN3O | 2201066-06-8 | Details |
2-Fluoro-N-methyl-4-nitrobenzamide | C8H7FN2O3 | 915087-24-0 | Details |
5-Chloro-6-[4-(ethoxycarbonyl)piperidino]-nicotinicacid | C14H17ClN2O4 | 931395-73-2 | Details |
Ozanimod Intermediate1 | C15H18N2O2 | 1306763-30-3 | Details |
Ozanimod Intermediate2 | C10H11ClN2 | 1306763-57-4 | Details |
Ozanimod Intermediate3 | C10H7NO | 60899-34-5 | Details |
Ozanimod Intermediate4 | C11H11NO3 | 258273-31-3 | Details |
(3R,4R)-1-benzyl-4-fluoropyrrolidin-3-amine bis-hydrochloride | C11H17Cl2FN2 | 2368804-56-0 | Details |
Baloxavir Intermediate | C6H15NO3 | 1228258-40-9 | Details |
Baloxavir Intermediate | C14H12O5 | 1332855-89-6 | Details |
Etravirine | C20H15BrN6O | 269055-15-4 | Details |
Baloxavir Intermediate | C14H10F2OS | 1985607-83-7 | Details |
Baloxavir Intermediate | C14H10F2O2S | 2136287-65-3 | Details |
Baloxavir Intermediate | C14H8F2OS | 2136287-66-4 | Details |
2-Fluoro-6-hydroxyphenylboronic acid | C6H6BFO3 | 1256345-60-4 | Details |
2(1H)-Pyridinone, 3-(aminomethyl)-4,6-dimethyl- (9CI) | C8H12N2O | 771579-27-2 | Details |
Perampanel Intermediate 1 | C10H8N2O | 381233-78-9 | Details |
7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione | C16H14ClFN4O2 | 2252403-82-8 | Details |
alpha-Methylimidazo[1,2-a]pyridine-6-methanamine | C9H11N3 | 1270475-03-0 | Details |
(2R)-2-ethynyl-2-methyl-1-pyrrolidineacetic acid 1,1-dimethylethyl ester | C13H21NO2 | 2086689-88-3 | Details |
(R)-3-(Boc-amino)pyrrolidine | C9H18N2O2 | 122536-77-0 | Details |
(R)-(-)-N-Boc-3-pyrrolidinol | C9H17NO3 | 109431-87-0 | Details |
Tetrabutylammonium[(2S,5R)-2-Carbamoyl7-oxo-1,6-diazabicyclo[3.2.1] octan-6-yl] Sulfate | C23H46N4O6S | 1192651-80-1 | Details |
N-(5-methoxy-2-phenoxyphenyl)methanesulfonamide | C14H15NO4S | 123664-84-6 | Details |
(3R)-(-)-3-Aminopyrrolidine dihydrochloride | C4H12Cl2N2 | 116183-81-4 | Details |
(R)-(-)-3-Pyrrolidinol hydrochloride | C4H10ClNO | 104706-47-0 | Details |
N-Boc, N-methylaminoacetone | C9H17NO3 | 532410-39-2 | Details |
Lifitegrast Intermediate 4 | C15H17Cl2NO4 | 851784-82-2 | Details |
Lifitegrast Intermediate 3 | C17H20ClNO4S | 1194550-59-8 | Details |
Lifitegrast Intermediate 5 | C16H19Cl2NO4 | 851784-80-0 | Details |
(S)-3-(Boc-amino)pyrrolidine | C9H18N2O2 | 122536-76-9 | Details |
(S)-1-Benzyl-pyrrolidine-3-aMine dihydrochloride | C11H18Cl2N2 | 131852-54-5 | Details |
N-(tert-Butoxycarbonyl)-(S)-(+)-3-pyrrolidinol | C9H17NO3 | 101469-92-5 | Details |
(S)-3-Hydroxypyrrolidine hydrochloride | C4H10ClNO | 122536-94-1 | Details |
(S)-(+)-1-Cbz-3-pyrrolidinol | C12H15NO3 | 100858-32-0 | Details |
1-Benzyl-3-(Boc-amino)pyrrolidine | C16H24N2O2 | 99735-30-5 | Details |
1-Boc-3-cyano-4-oxopyrrolidine | C10H14N2O3 | 175463-32-8 | Details |
N-Cbz-3-aminopyrrolidine | C12H16N2O2 | 185057-50-5 | Details |
Perampanel Intermediate 2 | C16H12N2O | 381725-50-4 | Details |
Perampanel Intermediate 3 | C16H11BrN2O | 381248-06-2 | Details |
2-Cyanophenylboronic acid 1,3-propanediol ester | C10H10BNO2 | 172732-52-4 | Details |
(2S,4R)-4-Fluoro-1-Fmoc-pyrrolidine-2-carboxylic acid | C20H18FNO4 | 203866-20-0 | Details |
Grazoprevir Intermediate | C16H22N2O6S2 | 1028252-16-5 | Details |
Grazoprevir Intermediate | C20H24ClN3O6 | 1206524-79-9 | Details |
Grazoprevir Intermediate | C9H8N2O3 | 31910-18-6 | Details |
Grazoprevir Intermediate | C9H6Cl2N2O | 39267-04-4 | Details |
Crizotinib Intermediate2 | C13H22BN3O4 | 1190875-39-8 | Details |
4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione | C15H13N3S | 1533519-84-4 | Details |
4-cyclopropylnaphthalen-1-aMinehydrochloride | C13H14ClN | 1533519-92-4 | Details |
Niraparib Intermediate1 | C9H7NO5 | 138229-59-1 | Details |
Niraparib Intermediate2 | C16H24N2O2 | 1171197-20-8 | Details |
Niraparib Intermediate3 | C11H16N2 | 19733-56-3 | Details |
Lifitegrast Impurity 29 | C9H6O3 | 77095-51-3 | Details |
N-BOC-3-Aminopiperidine | C10H20N2O2 | 184637-48-7 | Details |
(S)-3-Amino-1-N-Boc-piperidine | C10H20N2O2 | 625471-18-3 | Details |
(1S,6R)-6-AMINO-2,2-DIFLUOROCYCLOHEXAN-1-OL | C6H11F2NO | 1109284-40-3 | Details |
(S)-1-Boc-piperidine-2-carboxylic acid | C11H19NO4 | 26250-84-0 | Details |
1-Boc-4-methoxypiperidine | C11H21NO3 | 188622-27-7 | Details |
Ponatinib Intermediate | C6H4BrN3 | 18087-73-5 | Details |
Niraparib Intermediate5 | C9H8N2O2 | 755752-82-0 | Details |
Ponatinib Intermediate | C21H23F3IN3O | 943320-50-1 | Details |
(+/-)-1-N-Boc-Piperidine-2-carboxamide | C11H20N2O3 | 388077-74-5 | Details |
Ponatinib Intermediate | C6H5N3 | 766-55-2 | Details |
1-Piperidinecarboxylic acid, 4-(4-iodo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester | C13H20IN3O2 | 877399-73-0 | Details |
Ponatinib Intermediate | C8H5N3 | 943320-61-4 | Details |
Niraparib Intermediate6 | C11H14BrN | 769944-72-1 | Details |
(R)-Boc-Nipecotic acid | C11H19NO4 | 163438-09-3 | Details |
(R)-(+)-N-Boc-2-piperidinecarboxylic acid | C11H19NO4 | 28697-17-8 | Details |
1-Boc-3-Hydroxypiperidine | C10H19NO3 | 85275-45-2 | Details |
2-Amino-1,4:3,6-dianhydro-2-deoxy-D-mannitol | C6H11NO3 | 81621-62-7 | Details |
tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate | C19H32BN3O4 | 877399-74-1 | Details |
(R)-1-Boc-3-Aminopiperidine | C10H20N2O2 | 188111-79-7 | Details |
L-1-Cbz-Nipecotic acid | C14H17NO4 | 88466-74-4 | Details |
tert-Butyl 4-acetylpiperidine-1-carboxylate | C12H21NO3 | 206989-61-9 | Details |
3-Aminomethyl-1-N-Boc-piperidine | C11H22N2O2 | 162167-97-7 | Details |
Ponatinib Intermediate | C13H16F3N3O2 | 694499-24-6 | Details |
Niraparib Intermediate7 | C16H22BrNO2 | 1476776-55-2 | Details |
1-Boc-3-piperidinecarboxylic acid | C11H19NO4 | 84358-12-3 | Details |
Product Total: Product Page: | ||||
75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 |